SABRA HEALTH CARE REIT INC (SBRA) Fundamental Analysis & Valuation

NASDAQ:SBRA • US78573L1061

20.21 USD
-0.21 (-1.03%)
Last: Mar 4, 2026, 03:30 PM

This SBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, SBRA scores 4 out of 10 in our fundamental rating. SBRA was compared to 122 industry peers in the Diversified REITs industry. SBRA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SBRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. SBRA Profitability Analysis

1.1 Basic Checks

  • In the past year SBRA was profitable.
  • SBRA had a positive operating cash flow in the past year.
  • In multiple years SBRA reported negative net income over the last 5 years.
  • Each year in the past 5 years SBRA had a positive operating cash flow.
SBRA Yearly Net Income VS EBIT VS OCF VS FCFSBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • With a decent Return On Assets value of 2.83%, SBRA is doing good in the industry, outperforming 69.67% of the companies in the same industry.
  • With a decent Return On Equity value of 5.51%, SBRA is doing good in the industry, outperforming 64.75% of the companies in the same industry.
  • The Return On Invested Capital of SBRA (3.88%) is better than 71.31% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SBRA is in line with the industry average of 3.10%.
  • The last Return On Invested Capital (3.88%) for SBRA is above the 3 year average (3.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROIC 3.88%
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
SBRA Yearly ROA, ROE, ROICSBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • SBRA has a better Profit Margin (20.09%) than 69.67% of its industry peers.
  • In the last couple of years the Profit Margin of SBRA has declined.
  • SBRA has a Operating Margin of 34.06%. This is in the better half of the industry: SBRA outperforms 70.49% of its industry peers.
  • In the last couple of years the Operating Margin of SBRA has declined.
  • The Gross Margin of SBRA (66.87%) is comparable to the rest of the industry.
  • SBRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
SBRA Yearly Profit, Operating, Gross MarginsSBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. SBRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
  • Compared to 1 year ago, SBRA has more shares outstanding
  • SBRA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SBRA has a worse debt to assets ratio.
SBRA Yearly Shares OutstandingSBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SBRA Yearly Total Debt VS Total AssetsSBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.94, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of SBRA (0.94) is better than 70.49% of its industry peers.
  • SBRA has a Debt/Equity ratio of 0.90. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
  • SBRA has a Debt to Equity ratio of 0.90. This is in the better half of the industry: SBRA outperforms 62.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACC0.55
WACC7.01%
SBRA Yearly LT Debt VS Equity VS FCFSBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • SBRA has a Current Ratio of 1.48. This is a normal value and indicates that SBRA is financially healthy and should not expect problems in meeting its short term obligations.
  • SBRA's Current ratio of 1.48 is fine compared to the rest of the industry. SBRA outperforms 76.23% of its industry peers.
  • SBRA has a Quick Ratio of 1.48. This is a normal value and indicates that SBRA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.48, SBRA is in the better half of the industry, outperforming 77.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
SBRA Yearly Current Assets VS Current LiabilitesSBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

6

3. SBRA Growth Analysis

3.1 Past

  • SBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.75%, which is quite impressive.
  • Measured over the past years, SBRA shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.91% on average per year.
  • SBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
  • SBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.29% yearly.
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%

3.2 Future

  • SBRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.73% yearly.
  • SBRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.91% yearly.
EPS Next Y20.21%
EPS Next 2Y11.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2Y4.92%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

2

4. SBRA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.58, the valuation of SBRA can be described as expensive.
  • Based on the Price/Earnings ratio, SBRA is valued a bit cheaper than 63.11% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, SBRA is valued at the same level.
  • With a Price/Forward Earnings ratio of 26.27, SBRA can be considered very expensive at the moment.
  • 83.61% of the companies in the same industry are more expensive than SBRA, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, SBRA is valued at the same level.
Industry RankSector Rank
PE 31.58
Fwd PE 26.27
SBRA Price Earnings VS Forward Price EarningsSBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SBRA is valued a bit more expensive than the industry average as 60.66% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.74
SBRA Per share dataSBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y11.73%
EPS Next 3YN/A

5

5. SBRA Dividend Analysis

5.1 Amount

  • SBRA has a Yearly Dividend Yield of 5.75%, which is a nice return.
  • SBRA's Dividend Yield is a higher than the industry average which is at 7.07.
  • SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.75%

5.2 History

  • The dividend of SBRA decreases each year by -2.44%.
  • SBRA has paid a dividend for at least 10 years, which is a reliable track record.
  • SBRA has decreased its dividend recently.
Dividend Growth(5Y)-2.44%
Div Incr Years0
Div Non Decr Years1
SBRA Yearly Dividends per shareSBRA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • SBRA pays out 186.04% of its income as dividend. This is not a sustainable payout ratio.
DP186.04%
EPS Next 2Y11.73%
EPS Next 3YN/A
SBRA Yearly Income VS Free CF VS DividendSBRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
SBRA Dividend Payout.SBRA Dividend Payout, showing the Payout Ratio.SBRA Dividend Payout.PayoutRetained Earnings

SBRA Fundamentals: All Metrics, Ratios and Statistics

SABRA HEALTH CARE REIT INC

NASDAQ:SBRA (3/4/2026, 3:30:09 PM)

20.21

-0.21 (-1.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners98.72%
Inst Owner Change6.74%
Ins Owners1%
Ins Owner Change6.24%
Market Cap5.04B
Revenue(TTM)774.63M
Net Income(TTM)155.61M
Analysts76
Price Target21.97 (8.71%)
Short Float %9.39%
Short Ratio8.3
Dividend
Industry RankSector Rank
Dividend Yield 5.75%
Yearly Dividend1.18
Dividend Growth(5Y)-2.44%
DP186.04%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.68%
Min EPS beat(2)-51.75%
Max EPS beat(2)-37.61%
EPS beat(4)1
Avg EPS beat(4)-10.49%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-12.84%
EPS beat(12)2
Avg EPS beat(12)-37.62%
EPS beat(16)3
Avg EPS beat(16)-70.46%
Revenue beat(2)1
Avg Revenue beat(2)6.1%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)3.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)12.46%
Revenue beat(8)7
Avg Revenue beat(8)2.98%
Revenue beat(12)8
Avg Revenue beat(12)2%
Revenue beat(16)10
Avg Revenue beat(16)1.09%
PT rev (1m)3.32%
PT rev (3m)3.8%
EPS NQ rev (1m)-1.1%
EPS NQ rev (3m)-3.57%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)6.17%
Revenue NQ rev (3m)5.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 31.58
Fwd PE 26.27
P/S 6.51
P/FCF N/A
P/OCF 14.46
P/B 1.79
P/tB 1.83
EV/EBITDA 16.74
EPS(TTM)0.64
EY3.17%
EPS(NY)0.77
Fwd EY3.81%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)1.4
OCFY6.92%
SpS3.11
BVpS11.32
TBVpS11.05
PEG (NY)1.56
PEG (5Y)N/A
Graham Number12.77
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROCE 4.91%
ROIC 3.88%
ROICexc 3.93%
ROICexgc 3.98%
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
FCFM N/A
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
ROICexc(3y)3.75%
ROICexc(5y)3.51%
ROICexgc(3y)3.78%
ROICexgc(5y)3.54%
ROCE(3y)4.7%
ROCE(5y)4.39%
ROICexgc growth 3Y5.81%
ROICexgc growth 5Y1.97%
ROICexc growth 3Y5.63%
ROICexc growth 5Y2.01%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 242.22%
Cap/Sales 58.47%
Interest Coverage 2.38
Cash Conversion 77.32%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 0.94
F-Score5
WACC7.01%
ROIC/WACC0.55
Cap/Depr(3y)121.85%
Cap/Depr(5y)94.04%
Cap/Sales(3y)30%
Cap/Sales(5y)24.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
EPS Next Y20.21%
EPS Next 2Y11.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
Revenue Next Year5.71%
Revenue Next 2Y4.92%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%
EBIT growth 1Y2.66%
EBIT growth 3Y4%
EBIT growth 5Y0.26%
EBIT Next Year83.99%
EBIT Next 3Y26.83%
EBIT Next 5YN/A
FCF growth 1Y-159.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.26%
OCF growth 3Y3.36%
OCF growth 5Y-0.36%

SABRA HEALTH CARE REIT INC / SBRA FAQ

What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SBRA.


Can you provide the valuation status for SABRA HEALTH CARE REIT INC?

ChartMill assigns a valuation rating of 2 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Overvalued.


How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?

SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for SBRA stock?

The Earnings per Share (EPS) of SABRA HEALTH CARE REIT INC (SBRA) is expected to grow by 20.21% in the next year.


How sustainable is the dividend of SABRA HEALTH CARE REIT INC (SBRA) stock?

The dividend rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10 and the dividend payout ratio is 186.04%.